Clinical report - Guidelines for the determination of brain death in infants and children: An update of the 1987 task force recommendations

Thomas Nakagawa, Stephen Ashwal, Mudit Mathur, Mohan Mysore, Laura Kolinski, Lynn Retford, M. Michele Moss, Tim Yeh, Lorry Frankel, Roman Jaeschke

Research output: Contribution to journalReview article

Abstract

OBJECTIVE: To review and revise the 1987 pediatric brain death guidelines. METHODS: Relevant literature was reviewed. Recommendations were developed using the GRADE system. CONCLUSIONS AND RECOMMENDATIONS: (1) Determination of brain death in term newborns, infants and children is a clinical diagnosis based on the absence of neurologic function with a known irreversible cause of coma. Because of insufficient data in the literature, recommendations for preterm infants less than 37 weeks gestational age are not included in this guideline. (2) Hypotension, hypothermia, and metabolic disturbances should be treated and corrected and medications that can interfere with the neurologic examination and apnea testing should be discontinued allowing for adequate clearance before proceeding with these evaluations. (3) Two examinations including apnea testing with each examination separated by an observation period are required. Examinations should be performed by different attending physicians. Apnea testing may be performed by the same physician. An observation period of 24 hours for term newborns (37 weeks gestational age) to 30 days of age, and 12 hours for infants and chi (> 30 days to 18 years) is recommended. The first examination determines the child has met the accepted neurologic examination criteria for brain death. The second examination confirms brain death based on an unchanged and irreversible condition. Assessment of neurologic function following cardiopulmonary resuscitation or other severe acute brain injuries should be deferred for 24 hours or longer if there are concerns or inconsistencies in the examination. (4) Apnea testing to support the diagnosis of brain death must be performed safely and requires documentation of an arterial PaCO2 20mm Hg above the baseline and ≥ 60mm Hg with no respiratory effort during the testing period. If the apnea test cannot be safely completed, an ancillary study should be performed. (5) Ancillary studies (electroencephalogram and radionuclide cerebral blood flow) are not required to establish brain death and are not a substitute for the neurologic examination. Ancillary studies may be us d to assist the clinician in making the diagnosis of brain death (i) when components of the examination or apnea testing cannot be completed safely due to the underlying medical condition of the patient; (ii) if there is uncertainty about the results of the neurologic examination; (iii) if a medication effect may be present; or (iv) to reduce the inter-examination observation period. When ancillary studies are used, a second clinical examination and apnea test should be performed and components that can be completed must remain consistent with brain death. In this instance the observation interval may be shortened and the second neurologic examination and apnea test (or all components that are able to be completed safely) can be performed at any time thereafter.

Original languageEnglish (US)
JournalPediatrics
Volume128
Issue number3
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Brain Death
Advisory Committees
Apnea
Guidelines
Neurologic Examination
Observation
Nervous System
Gestational Age
Cerebrovascular Circulation
Newborn Infant
Physicians
Cardiopulmonary Resuscitation
Hypothermia
Premature Infants
Radioisotopes
Documentation
Hypotension
Brain Injuries
Uncertainty
Electroencephalography

Keywords

  • Apnea testing
  • Brain death
  • Cerebral blood flow
  • Children
  • Electroencephalography
  • Infants
  • Neonates
  • Pediatrics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Clinical report - Guidelines for the determination of brain death in infants and children : An update of the 1987 task force recommendations. / Nakagawa, Thomas; Ashwal, Stephen; Mathur, Mudit; Mysore, Mohan; Kolinski, Laura; Retford, Lynn; Moss, M. Michele; Yeh, Tim; Frankel, Lorry; Jaeschke, Roman.

In: Pediatrics, Vol. 128, No. 3, 09.2011.

Research output: Contribution to journalReview article

Nakagawa, T, Ashwal, S, Mathur, M, Mysore, M, Kolinski, L, Retford, L, Moss, MM, Yeh, T, Frankel, L & Jaeschke, R 2011, 'Clinical report - Guidelines for the determination of brain death in infants and children: An update of the 1987 task force recommendations', Pediatrics, vol. 128, no. 3. https://doi.org/10.1542/peds.2011-1511
Nakagawa, Thomas ; Ashwal, Stephen ; Mathur, Mudit ; Mysore, Mohan ; Kolinski, Laura ; Retford, Lynn ; Moss, M. Michele ; Yeh, Tim ; Frankel, Lorry ; Jaeschke, Roman. / Clinical report - Guidelines for the determination of brain death in infants and children : An update of the 1987 task force recommendations. In: Pediatrics. 2011 ; Vol. 128, No. 3.
@article{5319bc97b78a4b5cadb5c2c1557f467e,
title = "Clinical report - Guidelines for the determination of brain death in infants and children: An update of the 1987 task force recommendations",
abstract = "OBJECTIVE: To review and revise the 1987 pediatric brain death guidelines. METHODS: Relevant literature was reviewed. Recommendations were developed using the GRADE system. CONCLUSIONS AND RECOMMENDATIONS: (1) Determination of brain death in term newborns, infants and children is a clinical diagnosis based on the absence of neurologic function with a known irreversible cause of coma. Because of insufficient data in the literature, recommendations for preterm infants less than 37 weeks gestational age are not included in this guideline. (2) Hypotension, hypothermia, and metabolic disturbances should be treated and corrected and medications that can interfere with the neurologic examination and apnea testing should be discontinued allowing for adequate clearance before proceeding with these evaluations. (3) Two examinations including apnea testing with each examination separated by an observation period are required. Examinations should be performed by different attending physicians. Apnea testing may be performed by the same physician. An observation period of 24 hours for term newborns (37 weeks gestational age) to 30 days of age, and 12 hours for infants and chi (> 30 days to 18 years) is recommended. The first examination determines the child has met the accepted neurologic examination criteria for brain death. The second examination confirms brain death based on an unchanged and irreversible condition. Assessment of neurologic function following cardiopulmonary resuscitation or other severe acute brain injuries should be deferred for 24 hours or longer if there are concerns or inconsistencies in the examination. (4) Apnea testing to support the diagnosis of brain death must be performed safely and requires documentation of an arterial PaCO2 20mm Hg above the baseline and ≥ 60mm Hg with no respiratory effort during the testing period. If the apnea test cannot be safely completed, an ancillary study should be performed. (5) Ancillary studies (electroencephalogram and radionuclide cerebral blood flow) are not required to establish brain death and are not a substitute for the neurologic examination. Ancillary studies may be us d to assist the clinician in making the diagnosis of brain death (i) when components of the examination or apnea testing cannot be completed safely due to the underlying medical condition of the patient; (ii) if there is uncertainty about the results of the neurologic examination; (iii) if a medication effect may be present; or (iv) to reduce the inter-examination observation period. When ancillary studies are used, a second clinical examination and apnea test should be performed and components that can be completed must remain consistent with brain death. In this instance the observation interval may be shortened and the second neurologic examination and apnea test (or all components that are able to be completed safely) can be performed at any time thereafter.",
keywords = "Apnea testing, Brain death, Cerebral blood flow, Children, Electroencephalography, Infants, Neonates, Pediatrics",
author = "Thomas Nakagawa and Stephen Ashwal and Mudit Mathur and Mohan Mysore and Laura Kolinski and Lynn Retford and Moss, {M. Michele} and Tim Yeh and Lorry Frankel and Roman Jaeschke",
year = "2011",
month = "9",
doi = "10.1542/peds.2011-1511",
language = "English (US)",
volume = "128",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Clinical report - Guidelines for the determination of brain death in infants and children

T2 - An update of the 1987 task force recommendations

AU - Nakagawa, Thomas

AU - Ashwal, Stephen

AU - Mathur, Mudit

AU - Mysore, Mohan

AU - Kolinski, Laura

AU - Retford, Lynn

AU - Moss, M. Michele

AU - Yeh, Tim

AU - Frankel, Lorry

AU - Jaeschke, Roman

PY - 2011/9

Y1 - 2011/9

N2 - OBJECTIVE: To review and revise the 1987 pediatric brain death guidelines. METHODS: Relevant literature was reviewed. Recommendations were developed using the GRADE system. CONCLUSIONS AND RECOMMENDATIONS: (1) Determination of brain death in term newborns, infants and children is a clinical diagnosis based on the absence of neurologic function with a known irreversible cause of coma. Because of insufficient data in the literature, recommendations for preterm infants less than 37 weeks gestational age are not included in this guideline. (2) Hypotension, hypothermia, and metabolic disturbances should be treated and corrected and medications that can interfere with the neurologic examination and apnea testing should be discontinued allowing for adequate clearance before proceeding with these evaluations. (3) Two examinations including apnea testing with each examination separated by an observation period are required. Examinations should be performed by different attending physicians. Apnea testing may be performed by the same physician. An observation period of 24 hours for term newborns (37 weeks gestational age) to 30 days of age, and 12 hours for infants and chi (> 30 days to 18 years) is recommended. The first examination determines the child has met the accepted neurologic examination criteria for brain death. The second examination confirms brain death based on an unchanged and irreversible condition. Assessment of neurologic function following cardiopulmonary resuscitation or other severe acute brain injuries should be deferred for 24 hours or longer if there are concerns or inconsistencies in the examination. (4) Apnea testing to support the diagnosis of brain death must be performed safely and requires documentation of an arterial PaCO2 20mm Hg above the baseline and ≥ 60mm Hg with no respiratory effort during the testing period. If the apnea test cannot be safely completed, an ancillary study should be performed. (5) Ancillary studies (electroencephalogram and radionuclide cerebral blood flow) are not required to establish brain death and are not a substitute for the neurologic examination. Ancillary studies may be us d to assist the clinician in making the diagnosis of brain death (i) when components of the examination or apnea testing cannot be completed safely due to the underlying medical condition of the patient; (ii) if there is uncertainty about the results of the neurologic examination; (iii) if a medication effect may be present; or (iv) to reduce the inter-examination observation period. When ancillary studies are used, a second clinical examination and apnea test should be performed and components that can be completed must remain consistent with brain death. In this instance the observation interval may be shortened and the second neurologic examination and apnea test (or all components that are able to be completed safely) can be performed at any time thereafter.

AB - OBJECTIVE: To review and revise the 1987 pediatric brain death guidelines. METHODS: Relevant literature was reviewed. Recommendations were developed using the GRADE system. CONCLUSIONS AND RECOMMENDATIONS: (1) Determination of brain death in term newborns, infants and children is a clinical diagnosis based on the absence of neurologic function with a known irreversible cause of coma. Because of insufficient data in the literature, recommendations for preterm infants less than 37 weeks gestational age are not included in this guideline. (2) Hypotension, hypothermia, and metabolic disturbances should be treated and corrected and medications that can interfere with the neurologic examination and apnea testing should be discontinued allowing for adequate clearance before proceeding with these evaluations. (3) Two examinations including apnea testing with each examination separated by an observation period are required. Examinations should be performed by different attending physicians. Apnea testing may be performed by the same physician. An observation period of 24 hours for term newborns (37 weeks gestational age) to 30 days of age, and 12 hours for infants and chi (> 30 days to 18 years) is recommended. The first examination determines the child has met the accepted neurologic examination criteria for brain death. The second examination confirms brain death based on an unchanged and irreversible condition. Assessment of neurologic function following cardiopulmonary resuscitation or other severe acute brain injuries should be deferred for 24 hours or longer if there are concerns or inconsistencies in the examination. (4) Apnea testing to support the diagnosis of brain death must be performed safely and requires documentation of an arterial PaCO2 20mm Hg above the baseline and ≥ 60mm Hg with no respiratory effort during the testing period. If the apnea test cannot be safely completed, an ancillary study should be performed. (5) Ancillary studies (electroencephalogram and radionuclide cerebral blood flow) are not required to establish brain death and are not a substitute for the neurologic examination. Ancillary studies may be us d to assist the clinician in making the diagnosis of brain death (i) when components of the examination or apnea testing cannot be completed safely due to the underlying medical condition of the patient; (ii) if there is uncertainty about the results of the neurologic examination; (iii) if a medication effect may be present; or (iv) to reduce the inter-examination observation period. When ancillary studies are used, a second clinical examination and apnea test should be performed and components that can be completed must remain consistent with brain death. In this instance the observation interval may be shortened and the second neurologic examination and apnea test (or all components that are able to be completed safely) can be performed at any time thereafter.

KW - Apnea testing

KW - Brain death

KW - Cerebral blood flow

KW - Children

KW - Electroencephalography

KW - Infants

KW - Neonates

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=80052346872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052346872&partnerID=8YFLogxK

U2 - 10.1542/peds.2011-1511

DO - 10.1542/peds.2011-1511

M3 - Review article

C2 - 21873704

AN - SCOPUS:80052346872

VL - 128

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -